Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000195

President-Protein Sciences sold 11,357 shares at an average $261.45 ($2,969,274)

  • President-Protein Sciences acquired 11,357 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eansor Norman David President-Protein Sciences 2020-05-28 Option exercise +3,448 $108.49 $374,074 3,448 D: show line 1 in the form
Eansor Norman David President-Protein Sciences 2020-05-28 Sale −3,448 $260.19 $897,134 0 D: show line 2 in the form
Eansor Norman David President-Protein Sciences 2020-05-29 Option exercise +7,909 $108.49 $858,047 7,909 D: show line 3 in the form
Eansor Norman David President-Protein Sciences 2020-05-29 Sale −1,700 $260.83 $443,410 6,209 D: show line 4 in the form
Eansor Norman David President-Protein Sciences 2020-05-29 Sale −3,400 $261.74 $889,927 2,809 D: show line 5 in the form
Eansor Norman David President-Protein Sciences 2020-05-29 Sale −2,100 $262.68 $551,619 709 D: show line 6 in the form
Eansor Norman David President-Protein Sciences 2020-05-29 Sale −709 $264.01 $187,184 0 D: show line 7 in the form
Open-market sales · 11,357 sh · avg $261.45 · $2,969,274

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Eansor Norman David President-Protein Sciences 2020-05-28 Option exercise · Stock Options (Right to Buy) −3,448 7,909 D: show line 8 in the form
Eansor Norman David President-Protein Sciences 2020-05-29 Option exercise · Stock Options (Right to Buy) −7,909 0 D: show line 9 in the form
Loading xslF345X03/edgar.xml…